ArticleAmerican journal of respiratory and critical care medicine2023

Promise and Peril of Pretomanid-Rifamycin Regimens for Drug-susceptible Tuberculosis.

Gustavo E Velásquez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.